carbamazepine has been researched along with Macular Degeneration in 3 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aims of our study were to evaluate whether color vision and macular function are impaired in epileptic adolescents, to study if the monotherapy with valproic acid (VPA) and carbamazepine (CBZ) can affect color vision and macular function and to determine the possible relationship between color vision, retinal function and antiepileptic drugs (AEDs) dosage and their serum concentrations." | 2.72 | Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine. ( Chiarelli, F; Gallenga, PE; Iannetti, P; Lobefalo, L; Spalice, A; Tocco, AM; Verrotti, A, 2006) |
| "To report a case of subacute sclerosing panencephalitis in which the initial clinical presentations were optic atrophy and macular degeneration." | 1.32 | Optic atrophy and macular degeneration as initial presentations of subacute sclerosing panencephalitis. ( Aslan, O; Batman, C; Berker, N; Guven, A; Ozalp, S; Zilelioglu, O, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berker, N | 1 |
| Batman, C | 1 |
| Guven, A | 1 |
| Ozalp, S | 1 |
| Aslan, O | 1 |
| Zilelioglu, O | 1 |
| Verrotti, A | 1 |
| Lobefalo, L | 1 |
| Tocco, AM | 1 |
| Spalice, A | 1 |
| Gallenga, PE | 1 |
| Chiarelli, F | 1 |
| Iannetti, P | 1 |
| Görgens, K | 1 |
| Liedtke, M | 1 |
1 trial available for carbamazepine and Macular Degeneration
| Article | Year |
|---|---|
Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Color Perception; Epilepsy; Female | 2006 |
2 other studies available for carbamazepine and Macular Degeneration
| Article | Year |
|---|---|
Optic atrophy and macular degeneration as initial presentations of subacute sclerosing panencephalitis.
Topics: Analgesics, Non-Narcotic; Antibodies, Viral; Antiviral Agents; Carbamazepine; Cerebrospinal Fluid; C | 2004 |
[Charles Bonnet syndrome].
Topics: Aged; Aged, 80 and over; Carbamazepine; Diagnosis, Differential; Female; Hallucinations; Humans; Mac | 1998 |